tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Marcon, 94 are a BUY (63.51%), 54 are a HOLD (36.49%).
Analyst Mark Marcon, currently employed at BAIRD, carries an average stock price target met ratio of 60.87% that have a potential upside of 16.11% achieved within 191 days.
Mark Marcon’s has documented 310 price targets and ratings displayed on 20 stocks. The coverage is on Healthcare, Industrials, Technology sectors.
Most recent stock forecast was given on PYCR, Paycor HCM at 07-Feb-2025.
Analyst best performing recommendations are on HQY (HEALTHEQUITY).
The best stock recommendation documented was for HQY (HEALTHEQUITY) at 3/18/2020. The price target of $47 was fulfilled within 6 days with a profit of $6.46 (15.93%) receiving and performance score of 26.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$105
$-3.6 (-3.31%)
$100
2 months 12 days ago
(10-Dec-2024)
12/12 (100%)
$9.61 (10.07%)
226
Buy
$107
$-1.6 (-1.47%)
$105
2 months 12 days ago
(10-Dec-2024)
4/4 (100%)
$11.61 (12.17%)
163
Buy
$120
$11.4 (10.50%)
$105
2 months 20 days ago
(02-Dec-2024)
18/19 (94.74%)
$18.34 (18.04%)
194
Buy
$130
$21.4 (19.71%)
$110
3 months 8 days ago
(14-Nov-2024)
2/3 (66.67%)
$34.3 (35.84%)
558
Buy
$120
$11.4 (10.50%)
$100
3 months 9 days ago
(13-Nov-2024)
13/14 (92.86%)
$25.2 (26.58%)
116
Which stock is Mark Marcon is most bullish on?
What Year was the first public recommendation made by Mark Marcon?
